General call to Italy from the EU
By the European Commission reaches a recall to the Italian authorities because as soon as you put up with Community legislation.
According to the Commission, in fact, the Italian legislation would harm the manufacturers of generics, because of the lengthy procedures for the marketing of drugs, which delays the arrival on the market.
Greg Perry, president of the European Association of Manufacturers of generic drugs (Ega), comments << In this time of severe economic hardship and that European citizens and the health authorities are facing, it is crucial that access to less expensive treatments to be navigated without unnecessary delays. The delay in access to generic drugs was declared unacceptable by the investigation into the pharmaceutical sector of the European Commission, and also the current economic crisis makes this phenomenon >> totally unjustifiable.